Inoculating and boosting against HIV vaccine misinformation among adolescent girls and young women in South Africa
Inoculating and boosting against HIV vaccine misinformation among adolescent girls and young women in South Africa
批准号:
10620056
负责人:
Alison Meredith Buttenheim
金额:
$64.55万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-22 至 2028-02-29
关键词:
2 arm randomized control trialAfrica South of the SaharaAttentionBehavioralBehavioral trialCOVID-19 pandemicCOVID-19 vaccineCharacteristicsCognitiveCommunicationComplementContractsDecision MakingEpidemicExposure toFemale AdolescentsFutureGoalsHIVHIV InfectionsHIV riskHIV vaccineHearingImmunityIncidenceIndividualInstitutionMedical ResearchMisinformationPatternPopulationProvinceRandomized, Controlled TrialsRecording of previous eventsReportingResistanceSafetyScienceSouth AfricaSubgroupSurveysTestingTimeTrustVaccinationVaccinesVisitVulnerable PopulationsWorkagedbehavioral economicsdesignefficacy evaluationexperiencefightingfollow-upheuristicshigh riskinfodemicinnovationinsightinterestlifetime risknovelpre-exposure prophylaxisprogramspsychologicrecruitresponsetheoriesvaccine acceptancevaccine candidatevaccine hesitancyvaccine trialvaccine-induced immunitywillingnessyoung woman
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
A safe, effective, affordable and acceptable vaccine against HIV has been an epidemic-ending goal for decades,
and recent years have seen substantial progress towards developing and testing promising candidate vaccines.
For highly vulnerable groups like adolescent girls and young women (AGYW) in sub-Saharan Africa, access and
uptake of vaccines will be essential for reducing the exceptionally high HIV incidence observed in recent years.
This is particularly true in South Africa, which has the world's largest HIV epidemic and several active HIV vaccine
trial programs. While an HIV vaccine has the potential to substantially reduce HIV risk, realizing this potential will
require widespread vaccine uptake. Unfortunately, the lived experiences of both the HIV epidemic and the
ongoing COVID-19 pandemic have laid the groundwork for an infodemic of misinformation about the HIV
vaccine. Likely attributes of the HIV vaccine (e.g., partial protection against HIV), low trust in governmental and
medical research institutions, and poor understanding of how vaccines work will leave an HIV vaccine program
vulnerable to misinformation among the populations who would most benefit from vaccine-induced protection.
To realize the benefits of future HIV vaccines, novel communication strategies are needed to “inoculate”
individuals at highest risk of HIV infection against contagious vaccine misinformation. In this study, we bring
together two promising approaches – psychological inoculation theory and behavioral economics – to fight HIV
vaccine misinformation. Psychological inoculation theory offers a compelling approach to building “resistance”
to vaccine misinformation through explicit exposure to a “weakened” version (via direct refutation) of false
arguments underlying misinformation, before stronger versions of misinformation are encountered. Importantly,
by
posits
debunking
prebunking (or pre-emptively warning individuals about) emerging misinformation, inoculation theory also
that t hey will be better able to r esist future misinformation. Prebunking avoids the greater challenge of
once misinformation has lodged. In addition, behavioral economics provides a complementary
framework that recognize the cognitive and attentional constraints faced by individuals and can inform more
effective inoculation messages. We propose a randomized controlled trial of inoculation messages with a
behavioral economics “boost” with AGYW in South Africa, a population highly vulnerable to both HIV infection
and to vaccine misinformation. Mirroring a vaccine trial, our behavioral trial will evaluate the efficacy, safety,
durability, and generalized immunity effects of inoculation messages that are boosted with behavioral economics
insights. We will also evaluate differential responses to the messages by important subgroups of AGYW. This
proof--of-concept project has the potential to identify innovative communication strategies to build resistance to
emerging and evolving HIV vaccine misinformation. Results from the study will advance the science of HIV
vaccine demand creation and inoculation-theory based approaches to vaccine communication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving HIV testing, linkage, and retention in care for men through U=U messaging
-
批准号:10626959
-
项目类别:
-
资助金额:$54.37万
-
财政年份:2022
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving HIV testing, linkage, and retention in care for men through U=U messaging
-
批准号:10483486
-
项目类别:
-
资助金额:$59.2万
-
财政年份:2022
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Research Program
-
批准号:10460466
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2020
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Research Program
-
批准号:10225990
-
项目类别:
-
资助金额:$66.76万
-
财政年份:2020
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Research Program
-
批准号:10683409
-
项目类别:
-
资助金额:$62.33万
-
财政年份:2020
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:8759325
-
项目类别:
-
资助金额:$56.56万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:8917290
-
项目类别:
-
资助金额:$52.26万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Vaccination status of children exempted from school-entry immunization mandates
-
批准号:8750180
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:9091592
-
项目类别:
-
资助金额:$50.66万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:9318573
-
项目类别:
-
资助金额:$51.21万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Methods Core
-
批准号:9376072
-
项目类别:
-
资助金额:$24.37万
-
财政年份:--
-
负责人:Alison Meredith Buttenheim
-
依托单位:
海外基金